Bills on related subjects, starting with New Jersey.
Pharmacists or their designees would have to notify consumers when dispensing substituted drugs or biological products; existing substitution conditions would remain.
Status
Introduced, Referred to Assembly Financial Institutions and Insurance Committee
Status
In Progress
Status
In Progress
Status
In Progress